Market Tracker

04/23 6:05pm ET

GenMark Diagnostics Inc (NASDAQ:GNMK)

9.06
Data as of Apr 23
 -0.32 / -3.41%
Today’s Change
8.75
Today|||52-Week Range
16.00
-31.83%
Year-to-Date

Today’s Trading

Previous close9.38
Today’s open9.35
Day’s range9.03 - 9.53
Volume155,722
Average volume (3 months)214,231
Market cap$405.7M
Dividend yield--
Data as of 3:59pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-13.10%
Earnings growth (this year)-22.74%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+33.88%
P/E ratioNM
Price/Sales17.10
Price/Book3.68

Competitors

 Today’s
change
Today’s
% change
CTICCell Therapeutics In...-0.15-4.50%
NBSNeoStem Inc0.000.00%
RDNTRadNet Inc-0.07-1.43%
NEONeogenomics Inc-0.07-2.03%
Data as of 3:59pm ET, 04/23/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$27.4M
Annual profit (last year)-$33.6M
Net profit margin-122.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Senior VP-Global Operations &
Human Resources
Jennifer Anne Williams
Corporate headquarters
Carlsbad, California

Forecasts